Evox Therapeutics Competitors and Similar CompaniesClear all
Protalex's competitors and similar companies include Biocept and Codiak Biosciences.
 Protalex Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases. |  Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | |
Founding Date | Founding Date 1999 | Founding Date 1993 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Florham Park, US HQ | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 233% decrease | Employees 878% decrease | Employees 992% decrease |
Valuation ($) | Valuation ($) 615.2 k | Valuation ($) N/A | Valuation ($) 2.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $22.9m (FY, 2021) |
Net income | Net income ($5m) (FY, 2018) | Net income ($32.1m) (FY, 2022) | Net income ($37.2m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 15.9m | Total funding raised $ 168.5m |
For sources of this data, please see the company profile
View Company Profiles
Biocept
HQ
San Diego, US
Employees
87↓ 8% decrease
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company